
Sign up to save your podcasts
Or


In this episode, Nir Barzilai, director of the Institute for Aging Research and expert in the genetics of longevity, discusses the evidence that metformin and rapamycin have anti-aging properties and how his TAME study aims to support this hypothesis in humans. Additionally, he describes the role of genetics in lifespan/healthspan and how it might affect important pathways such as IGF and insulin sensitivity.
We discuss:
Learn more at www.PeterAttiaMD.com
Connect with Peter on Facebook | Twitter | Instagram.
By Peter Attia, MD4.7
75547,554 ratings
In this episode, Nir Barzilai, director of the Institute for Aging Research and expert in the genetics of longevity, discusses the evidence that metformin and rapamycin have anti-aging properties and how his TAME study aims to support this hypothesis in humans. Additionally, he describes the role of genetics in lifespan/healthspan and how it might affect important pathways such as IGF and insulin sensitivity.
We discuss:
Learn more at www.PeterAttiaMD.com
Connect with Peter on Facebook | Twitter | Instagram.

16,174 Listeners

7,224 Listeners

11,896 Listeners

2,035 Listeners

503 Listeners

2,642 Listeners

4,941 Listeners

3,462 Listeners

9,192 Listeners

154 Listeners

624 Listeners

1,141 Listeners

29,277 Listeners

1,243 Listeners

1,193 Listeners